PASITHEA THERAPEUTICS CORP.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $241.4K | $243.7K |
| FY2021 | — | $51.4M | $53.0M |
| FY2022 | — | $42.5M | $33.1M |
| FY2023 | — | $23.4M | $16.3M |
| FY2024 | — | $14.8M | $6.9M |
| FY2025 | — | $55.2M | $55.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $241.4K | $243.7K |
| FY2021 | — | $51.4M | $53.0M |
| FY2022 | — | $42.5M | $33.1M |
| FY2023 | — | $23.4M | $16.3M |
| FY2024 | — | $14.8M | $6.9M |
| FY2025 | — | $55.2M | $55.2M |